Page last updated: 2024-08-23

daunorubicin and pp242

daunorubicin has been researched along with pp242 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gong, Y; Naren, D; Shi, F; Shi, R; Wu, J; Yang, X	1

Other Studies

1 other study(ies) available for daunorubicin and pp242

Article	Year
The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia. Anti-cancer drugs, 2015, Volume: 26, Issue:4 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Synergism; Eukaryotic Initiation Factor-4E; Humans; Indoles; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Mantle-Cell; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Myeloid Cell Leukemia Sequence 1 Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Purines; Signal Transduction; TOR Serine-Threonine Kinases	2015

Article

Year

The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.

Anti-cancer drugs, 2015, Volume: 26, Issue:4

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Synergism; Eukaryotic Initiation Factor-4E; Humans; Indoles; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Mantle-Cell; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Myeloid Cell Leukemia Sequence 1 Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Purines; Signal Transduction; TOR Serine-Threonine Kinases

2015